Truqap is usually a kinase inhibitor that works by blocking pathways that support the cancer cells survive and develop, so reduces most cancers growth. Truqap is from a category of medicines called an AKT inhibitor. Truqap received FDA acceptance on November seventeen, 2023, immediately after favourable benefits with the CAPItello-291 https://lucianoo888dqb1.wikibuysell.com/user